Stem Cell Therapies

BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies | September 26, 2017

September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT...

CardiAMP Heart Failure Trial Design Presented at Texas Heart Institute Symposium
News | Heart Failure | September 25, 2017

September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure...

BioCardia Completes Roll-in Cohort in Pivotal Phase III CardiAMP Heart Failure Trial
News | Stem Cell Therapies | August 16, 2017

August 16, 2017 — BioCardia Inc. recently announced completion of treatment for the 10-patient roll-in cohort for...

New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies | August 04, 2017

August 4, 2017 — In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is...

SanBio Receives $20 Million Grant for Stroke Clinical Trial
News | Stroke | July 12, 2017

July 12, 2017 — SanBio Inc. recently announced it has been awarded a $20 million grant from the California Institute...

An example of porcine cartdiac stem cells. Photo from the University of Miami Miller School of Medicine.

 

News | Stem Cell Therapies | June 12, 2017

June 12, 2017 — Heart muscle is one of the least renewable tissues in the body, which is one of the reasons that...

Stem Cell Therapy Holds Promise for Treating Most Severe Cases of Angina
News | Stem Cell Therapies | May 12, 2017

May 12, 2017 — An analysis of data from the entire development program consisting of three trials assessing the...

3-D Printed Patch Can Help Mend a ‘Broken’ Heart

This photo shows the 3D-bioprinted cell patch in comparison to a mouse heart. When the patch was placed on a live mouse following a simulated heart attack, the researchers saw significant increase in functional capacity after just four weeks. Image courtesy of Patrick O’Leary, University of Minnesota.

News | Stem Cell Therapies | April 18, 2017

April 18, 2017 — A team of biomedical engineering researchers, led by the University of Minnesota, has created a...

Texas Heart Institute, ischemic heart failure, adult stem cell therapy, CONCERT-HF clinical trial
News | Stem Cell Therapies | February 03, 2017

February 3, 2017 — Physicians and researchers at Texas Heart Institute are recruiting patients who suffer from heart...

ischemic heart failure, stem cell therapy, MSCs, CSCs, Minneapolis Heart Institute Foundation, MHIF study
News | Heart Failure | January 10, 2017

January 10, 2017 — Ischemic heart...

News | Stem Cell Therapies | January 09, 2017

January 9, 2017 — BioCardia Inc. announced in December the issuance of United States Patent No. 9,517,199 relating...

News | Stem Cell Therapies | January 03, 2017

January 3, 2017 — BioCardia Inc. announced in December the initiation of the CardiAMP Heart Failure pivotal trial, a...

University of Houston, heart muscle cell regeneration, microRNAs, Yu Liu

A team of developmental biologists at the University of Houston have uncovered new regulators of heart formation that are easier to deliver into human bodies, and thus have a shorter path to clinical use. Image courtesy of Yu Liu.

News | Stem Cell Therapies | August 11, 2016

August 11, 2016 — Cardiovascular diseases are the leading cause of death in the United States. With one in every...

UAB, University of Alabama at Birmingham, Jianyi Jay Zhang, custom-engineered heart tissue
News | Stem Cell Therapies | June 28, 2016

June 24, 2016 — The University of Alabama at Birmingham (UAB) announced the launch of new research by Jianyi “Jay”...

Overlay Init